Nama's AI scorecard currently rates Novanta Buy (7.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is NOVT's P/E ratio?

Novanta trades at a trailing price-to-earnings ratio of 38.8.

When does NOVT report earnings?

Novanta's next scheduled report is on Nov 9, 2026. Analysts expect EPS of $0.97.

What is the NOVT price target?

The median analyst price target from 2 analysts is $194.50, with a range of $194.00 – $195.00.

Is NOVT Shariah compliant?

Nama's AAOIFI-style screen reads Novanta as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Nama Insights

Novanta (NOVT)

Technology · Scientific Technical Instruments · NASDAQ

Novanta (NOVT) is a Technology company in the Scientific Technical Instruments industry. It has a market capitalization of $5.11B, a trailing price-to-earnings ratio of 38.8 and a free-cash-flow yield of 1.0%. Over the most recent reported fiscal year, revenue grew 3.3% and free cash flow per share fell 66.3%. Nama's AI scorecard rates it Buy, 7.5 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Buy · 7.5/10

Clearly positive, short of the top band. As of Nov 7, 2026.

Momentum

Rising · +33.9% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-28.0%

How far the last close sits under the highest price of the past five years.

Market cap	$5.11B
Trailing P/E	38.8
Price / book	3.2
Price / sales	5.0
FCF yield	1.0%
Dividend yield	—
Gross margin	44.5%
Operating margin	11.7%
Net margin	6.0%
Revenue growth (YoY)	+3.3%
Revenue growth (3-yr annual)	+4.4%
EPS growth (YoY)	+6.5%
FCF/share growth (YoY)	-66.3%
Beta	1.7
Exchange	NASDAQ
Sector	Technology
Industry	Scientific Technical Instruments

NOVT earnings

Next report: Nov 9, 2026 (Q3 2026, EPS estimate $0.97). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2026	Aug 5, 2026	$0.89	$0.83	+7.2%	$265.81M
Q1 2026	May 11, 2026	$0.81	$0.78	+3.9%	$257.71M
Q4 2025	Feb 23, 2026	$0.91	$0.88	+3.4%	$258.35M
Q3 2025	Nov 3, 2025	$0.87	$0.82	+6.1%	$247.84M

NOVT analyst price target

Median target $194.50 from 2 analysts, ranging $194.00 – $195.00.

Scientific Technical Instruments peers

Ticker	Company	Market cap	P/E
GRMN	Garmin	$55.03B	27.4
KEYS	Keysight Technologies	$46.33B	27.2
COHR	Coherent	$37.98B	29.5
TDY	Teledyne Technologies	$28.68B	24.6
FTV	Fortive	$19.46B	21.0
MKSI	MKS	$13.00B	15.7
TRMB	Trimble	$12.40B	15.4
CGNX	Cognex	$8.04B	30.1

Explore live NOVT data on Nama Insights →

Recent Congressional trades

Novanta trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Jun 8, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Dec 15, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Sep 12, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025

NOVT FAQ

Is NOVT a buy?: Nama's AI scorecard currently rates Novanta Buy (7.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is NOVT's P/E ratio?: Novanta trades at a trailing price-to-earnings ratio of 38.8.
When does NOVT report earnings?: Novanta's next scheduled report is on Nov 9, 2026. Analysts expect EPS of $0.97.
What is the NOVT price target?: The median analyst price target from 2 analysts is $194.50, with a range of $194.00 – $195.00.
Is NOVT Shariah compliant?: Nama's AAOIFI-style screen reads Novanta as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.